Category Ranking
98%
Total Visits
921
Avg Visit Duration
2 minutes
Citations
20
Article Abstract
Βeta oscillatory activity (human: 13-35 Hz; primate: 8-24 Hz) is pervasive within the cortex and basal ganglia. Studies in Parkinson's disease patients and animal models suggest that beta-power increases with dopamine depletion. However, the exact relationship between oscillatory power, frequency and dopamine tone remains unclear. We recorded neural activity in the cortex and basal ganglia of healthy non-human primates while acutely and chronically up- and down-modulating dopamine levels. We assessed changes in beta oscillations in patients with Parkinson's following acute and chronic changes in dopamine tone. Here we show beta oscillation frequency is strongly coupled with dopamine tone in both monkeys and humans. Power, coherence between single-units and local field potentials (LFP), spike-LFP phase-locking, and phase-amplitude coupling are not systematically regulated by dopamine levels. These results demonstrate that beta frequency is a key property of pathological oscillations in cortical and basal ganglia networks.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8640051 | PMC |
| http://dx.doi.org/10.1038/s41467-021-27375-5 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Nutritional co-therapy with vitamin D and L-theanine reduces unpredictable mild chronic stress (UCMS) in aged mice by restoring alpha-oscillations, dopamine levels and behavioral improvement.
Exp Gerontol
September 2025
Department of Pharmacology, Faculty of Pharmacy, Bahauddin Zakariya University, Multan 60800, Pakistan. Electronic address:
Late-life depression (LLD) arises from the confluence of neurochemical dysfunction, oxidative stress, and neural network disintegration, presenting a formidable therapeutic challenge. Here, we demonstrated that combined vitamin D (Vit D) and L-theanine (L-thea) administration exerts multimodal neurorestorative effects in an aged murine model of unpredictable chronic mild stress (UCMS), addressing the core triad of LLD pathology: dopaminergic decline, redox imbalance, and thalamocortical dyssynchrony. Using a comprehensive battery of behavioral assays (Open Field Test, Elevated Plus Maze, Hole Board Test, Tail Suspension Test, Forced Swim Test, Sucrose Preference Test), we observed profound anxiogenic and anhedonic phenotypes in the UCMS-exposed mice, accompanied by elevated immobility and suppressed exploratory drive.
View Article and Find Full Text PDFBalancing Risk and Reward: Dopamine's Central Role in Economic Decision-Making.
Brain Sci
August 2025
DrLim Neuromodulation Lab, Department of Biosciences and Bioinformatics, School of Science, Xi'an Jiaotong-Liverpool University, Suzhou 215123, China.
Dopamine has been increasingly implicated in shaping economic and financial decision-making, yet much of the evidence remains fragmented across paradigms and mechanistic levels, and heavily based on preclinical or clinical populations. This review synthesises pharmacological, neuroimaging, and genetic findings from studies involving healthy human participants, highlighting dopamine's role in risk-taking, delay discounting, social fairness, reward sensitivity, and feedback learning. It distinguishes between transient state-related effects and stable trait-level influences, and clarifies how dopaminergic tone, receptor subtype activity-particularly D2-and corticostriatal circuitry modulate economic choices.
View Article and Find Full Text PDFMethylphenidate as a Novel Adjunct in Opioid-Taking Patients: Insights into Dopaminergic Neuroadaptation and Hypoactive Delirium.
Brain Sci
August 2025
Department and Clinic of Adult Psychiatry, Faculty of Medical Sciences, Medical University of Silesia, Ziolowa 45, 40-635 Katowice, Poland.
Background and aim of this review: The ongoing opioid epidemic underscores the urgent need for innovative pharmacological and behavioral interventions to mitigate the impact of opioid use disorder (OUD). This review aims to explore theoretical overlaps between the neurobiological mechanisms underlying OUD development and the pharmacodynamic profile of methylphenidate (MPH). Particular attention is given to the potential shared molecular targets, safety considerations, and therapeutic implications of MPH use in this clinical context.
View Article and Find Full Text PDFAsymmetric hand deformities with limited mobility.
Ann Rheum Dis
August 2025
Department of Neurology, Mianyang Central Hospital, University of Electronic Science and Technology of China, Mianyang, China. Electronic address:
A 52-year-old woman presented to the rheumatology department with a 6-year history of progressively limited hand mobility, bilateral joint pain, and worsening hand deformities. Examination revealed asymmetric deformities of both hands, more pronounced on the left (Fig, A), without joint tenderness, swelling, or Heberden's and Bouchard's nodes. Laboratory tests, including C-reactive protein, rheumatoid factor, anticyclic citrullinated peptide antibody, antinuclear antibody, antidouble-stranded DNA antibody, and anti-Smith antibody, revealed no abnormalities.
View Article and Find Full Text PDFRestless Legs Syndrome, Periodic Leg Movements, Hypertension and Cardiovascular Diseases.
Circ Res
August 2025
Department of Cardiovascular Medicine, Mayo Clinic, Rochester, MN (V.K.S.).
Restless legs syndrome (RLS) is a frequent sleep-related sensorimotor disorder defined by an urge to move the legs in the evening while resting. Severe RLS symptoms can negatively impact sleep, mood, and quality of life. Periodic leg movements during sleep and wakefulness are found in 60% to 80% of patients with RLS.
View Article and Find Full Text PDF